Osaid Alser

ORCID: 0000-0001-6743-803X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Cardiac, Anesthesia and Surgical Outcomes
  • Global Health and Surgery
  • Trauma and Emergency Care Studies
  • Health and Conflict Studies
  • Disaster Response and Management
  • Migration, Health and Trauma
  • Surgical site infection prevention
  • COVID-19 epidemiological studies
  • Global Health Workforce Issues
  • Diversity and Career in Medicine
  • Intensive Care Unit Cognitive Disorders
  • COVID-19 diagnosis using AI
  • Viral Infections and Outbreaks Research
  • Global Cancer Incidence and Screening
  • Dupuytren's Contracture and Treatments
  • Nail Diseases and Treatments
  • Peripheral Neuropathies and Disorders
  • Enhanced Recovery After Surgery
  • COVID-19 and Mental Health
  • Emergency and Acute Care Studies
  • Global Security and Public Health
  • Advances in Oncology and Radiotherapy

Islamic University of Gaza
2020-2025

Harvard University
2020-2024

Massachusetts General Hospital
2020-2024

Texas Tech University Health Sciences Center
2022-2023

Texas Tech University
2022-2023

RELX Group (United States)
2023

Faculty of 1000 (United States)
2023

Clinical Innovations (United States)
2023

Ministry of Health
2017-2023

Lubbock Christian University
2023

Dmitri Nepogodiev Aneel Bhangu James Glasbey Elizabeth Li Omar Omar and 95 more Joana F F Simoes Tom Abbott Osaid Alser Alexis Arnaud Brittany Bankhead-Kendall Kerry Breen Miguel F Cunha Giana H. Davidson Salomone Di Saverio Gaetano Gallo Ewen A. Griffiths Rohan R Gujjuri Peter Hutchinson Haytham M.A. Kaafarani Hans Lederhuber Markus Löffler Hassan Mashbari Ana Minaya‐Bravo Dion Morton David Moszkowicz Francesco Pata George Tsoulfas Mary L Venn Daniel Cox April Camilla Roslani Felix Alakaloko J.P. de Vries Mahmoud Al Aaraj Tom Abbott Tom Abbott Mutwakil OM Abdalla Ahmed Samir Abdelaal Adesoji Ademuyiwa Thomas Aherne Osman Ali Ghadah Z Alkadeeki Ana C. Almeida Mahmoud Maher Abdelnaby Alrahawy Graeme K. Ambler Ehab Alameer Stefano Andreani Beatriz De Andrés-Asenjo L López Antoñanzas Salah G. Aoun F Ashoush Knut Magne Augestad R Avellana Funbi Ayeni J Ayorinde B H Babu M. Baig O Bajomo Olivia Baker Markus Baker Alexander J. Baldwin Vin Shen Ban Ryan Baron Alberto G. Barranquero Conor Barry A Di bartolomeo Gary Alan Bass Michael Bath H. Hunt Batjer Andrew J. Beamish Ajay Belgaumkar Matthew N Bence Ruth Benson Juan Carlos Bernal-Sprekelsen Anuradha R. Bhama Avi Bhavaraju Walter L. Biffl Chris Blundell Alex Boddy Alexander B.J. Borgstein David C. Bosanquet Karen Bosch Ahmad Bouhuwaish Mehmet Abdussamet Bozkurt Collin EM Brathwaite Benjamin Brown Oliver Brown A Brown Igor Lima Buarque A.D. Bueno Cañones Mustafa R Bulugma Josh Burke Matthew H V Byrne Elima P Cagigal-Ortega Rachael A. Callcut Francesca Di Candido M Canova William Carlos Edward Caruana Liam D. Cato Andrew B Catton

10.1016/s0140-6736(20)31182-x article EN cc-by-nc-nd The Lancet 2020-05-29
Aneel Bhangu Adesoji Ademuyiwa María Lorena Aguilera Philip Alexander Sara W Al‐Saqqa and 95 more Giuliano Borda‐Luque Ainhoa Costas‐Chavarri Thomas M Drake Faustin Ntirenganya J.E.F. Fitzgerald Stuart J Fergusson James Glasbey JC Allen Ingabire Ismaïl Lawani Hosni Salem Anyomih Theophilus Teddy Kojo Marie Carmela Lapitan Richard Lilford André L. Mihaljević Dion Morton Alphonse Zeta Mutabazi Dmitri Nepogodiev Adewale Adisa Riinu Ots Francesco Pata Thomas Pinkney Tomas Poškus Ahmad Uzair Qureshi Antonio Ramos‐De la Medina Sarah Rayne Caitlin Shaw Sebastian Shu Richard T. Spence Neil Smart Stephen Tabiri Ewen M. Harrison Chetan Khatri Midhun Mohan Zahra Jaffry Afnan Altamini Andrew Kirby Kjetil Søreide Gustavo Recinos Jennifer Cornick María Marta Modolo Dushyant Iyer Sebastian King Thomas Arthur Sayeda Nazmum Nahar Ade Waterman Michael Walsh Arnav Agarwal Augusto Zani Mohammed Firdouse Tyler Rouse Alex Qinyang Liu Juan Camilo Correa Peep Talving Mengistu Worku Alexis Arnaud Vassilis Kalles Basant Kumar Sunil Kumar Radhian Amandito R Quek Luca Ansaloni Ahmed Altibi Donatas Venskutonis Justas Žilinskas Tomas Poškus John Whitaker Vanessa Msosa Yong Yong Tew Alexia Farrugia Elaine Borg Zineb Bentounsi Tanzeela Gala Ibrahim Al‐Slaibi Haya Tahboub Osaid Alser Diego Romani Sebestian Shu Piotr Major Aurel Mironescu Matei Răzvan Bratu Amar Kourdouli Aliyu Ndajiwo Abdulaziz Altwijri Mohammed Ubaid Alsaggaf Ahmad Gudal Al Faifi Jubran Sam Seisay Bettina Lieske Irene Ortega Jenifa Jeyakumar Kithsiri Janakantha Senanayake Omar Abdulbagi Yücel Cengiz Dmitri Raptis Yüksel Altınel

Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global priority not fully understood. We quantified burden SSI after gastrointestinal surgery in countries all parts world.

10.1016/s1473-3099(18)30101-4 article EN cc-by The Lancet Infectious Diseases 2018-02-13

Extrapulmonary disease has been observed in patients with coronavirus 2019 (COVID-19).1–3 We describe here the gastrointestinal (GI) complications of severe COVID-19 admitted to intensive care unit (ICU) at Massachusetts General Hospital between March 13 and April 12, 2020. During this time period, 141 were ICU acute respiratory syndrome 2 infection confirmed by reverse-transcriptase–polymerase-chain-reaction testing. The median (interquartile range) age was 57 (47, 70) years, 65% them men,...

10.1097/sla.0000000000004004 article EN Annals of Surgery 2020-05-07

Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid arthritis, has received much negative publicity for adverse events associated with its authorisation emergency use to treat patients COVID-19 pneumonia. We studied safety hydroxychloroquine, alone and combination azithromycin, determine risk routine care arthritis.

10.1016/s2665-9913(20)30276-9 article EN cc-by The Lancet Rheumatology 2020-08-21
Naomi Wright Andrew Leather Niyi Ade‐Ajayi Nick Sevdalis Justine Davies and 95 more Dan Poenaru Emmanuel A. Ameh Adesoji Ademuyiwa Kokila Lakhoo Emily R. Smith Abdel Douiri Maria Elstad Marcus Sim Cristiana Riboni Bruno Martínez-Leo Melika Akhbari Stephen Tabiri Ashrarur Rahman Mitul Dayang Anita Abdul Aziz Camila Girardi Fachin Alliance Niyukuri Muhammad Arshad Fowzia Ibrahim Natalie Moitt Mohamed Fahmy Doheim Hannah R. Thompson Harmony Ubhi Isabelle Williams Sophia Hashim Godfrey Sama Philipo Laura Herrera Aayenah Yunus Dominique Vervoort Samuel Parker Yousra-Imane Benaskeur Osaid Alser Nana Adofo-Ansong Ahmad Alhamid Hosni Salem Mahmoud Saleh Safa Elrais Sadi A. Abukhalaf Patricia Shinondo Ibrahim Nour Emrah Aydın Agota Vaitkienė Kelly Naranjo Andile Dube Sodumisa Ngwenya Mina A Yacoub Henang Kwasau Gabriella Hyman S M.elghazaly Ibrahim Al‐Slaibi Intisar Hisham Helena Franco Hana Arbab Lubna Samad Aqil Soomro Muhammad Amjad Chaudhry Safina Karim Muhammad Adnan Khattak Shireen Anne Nah Doris Mae Dimatatac Candy S. C. Choo Niveshni Maistry Ashrarur Rahman Mitul Samiul Hasan Sabbir Karim Hina Yousuf Taimur Qureshi Ibrahim Nour Raed Al-Taher Osama Abdul Kareem Sarhan Luis García‐Aparicio J. Prat Eva Blázquez-Gómez Xavier Tarrado Martí Iriondo P Bragagnini Rodríguez Segundo Rite Gracia Lars Hagander Emma Svensson Sheila Agyeiwaa Owusu Alhassan Abdul‐Mumin Dominic Bagbio Vijay Anand Ismavel Ann Miriam T Shajin Marlene Anaya Domínguez Monica Ivanov Andreea Mădălina Șerban Miliard Derbew Mahmoud Elfiky Maricarmen Olivos Perez Marcia Abrunhosa Matias Alexis Arnaud Ahmed Negida Sebastian King Mohamad Rafi Fazli

BackgroundCongenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital fatal without timely access to neonatal surgical care, but few studies have been done on these conditions low-income and middle-income countries (LMICs). We compared outcomes seven most common low-income, middle-income, high-income globally, identified factors associated with mortality.MethodsWe did a multicentre, international prospective cohort...

10.1016/s0140-6736(21)00767-4 article EN cc-by The Lancet 2021-07-01

ABSTRACT Background Hydroxychloroquine has recently received Emergency Use Authorization by the FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. We studied safety of hydroxychloroquine, alone azithromycin. Methods New user cohort studies were conducted including 16 severe adverse events (SAEs). Rheumatoid arthritis patients aged 18+ initiating hydroxychloroquine compared to those sulfasalazine followed up over 30 days. Self-controlled case series...

10.1101/2020.04.08.20054551 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2020-04-10

Abstract Comorbid conditions appear to be common among individuals hospitalised with coronavirus disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the prior medication use patients. Here, we describe characteristics adults COVID-19 compare them influenza We include 34,128 (US: 8362, South Korea: 7341, Spain: 18,425) patients, summarising between 4811 11,643 unique aggregate characteristics. patients have been majority male in US Spain, predominantly female...

10.1038/s41467-020-18849-z article EN cc-by Nature Communications 2020-10-06

Abstract Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents. Design Multinational network cohort study. Setting Hospital electronic health records from United States, Spain, China, nationwide claims data South Korea. Participants 303 264 January 2020 December 2020. Main outcome measures Prescriptions or dispensations any drug on 30 days after date admission for covid-19. Results Of included, 290 131 were...

10.1136/bmj.n1038 article EN cc-by BMJ 2021-05-11
Christina Fotopoulou Tabassum Khan Juraj Bracinik James Glasbey Nadeem Abu-Rustum and 95 more Luis Chiva Anna Fagotti Keiichi Fujiwara Rahel Ghebre Murat Gutelkin Thomas O. Konney Joseph Ng Rene Pareja Rajkumar Kottayasamy Seenivasagam Jalid Sehouli Shylasree Surappa Aneel Bhangu Elaine Leung Sudha Sundar Dmitri Nepogodiev Kwabena Siaw-Acheampong Ruth Benson Edward Bywater Daoud Chaudhry Brett E Dawson Jonathan P Evans James Glasbey Rohan R Gujjuri Emily Heritage Conor Jones Sivesh K. Kamarajah Chetan Khatri Rachel A Khaw James M Keatley Andrew T. Knight Samuel Lawday Elizabeth Li Harvinder Mann Ella J Marson Kenneth A McLean S McKay Emily Mills Gianluca Pellino Maria Picciochi Elliott H Taylor Abhinav Tiwari Joana Simões Isobel M Trout Mary L Venn Richard Wilkin Aneel Bhangu Joana Simões Tom Abbott Sadi A. Abukhalaf Michel Adamina Adesoji Ademuyiwa Arnav Agarwal Murat Akkulak Ehab Alameer Derek Alderson Felix Alakaloko Markus Albertsmeier Osaid Alser Muhammad Alshaar Sattar Alshryda Alexis P. Arnaud Knut Magne Augestad Faris Ayasra José Azevedo Brittany Bankhead-Kendall Emma Barlow David Beard Ruth Benson Ruth Blanco‐Colino Amanpreet Brar Ana Minaya‐Bravo Kerry Breen Chris Bretherton Igor Lima Buarque Josh Burke Edward Caruana Mohamad K. Abou Chaar Sohini Chakrabortee Peter Christensen Daniel Cox Moisés Cukier Miguel F Cunha Giana H. Davidson Anant Desai Salomone Di Saverio Thomas M Drake John Edwards Muhammed Elhadi Sameh Hany Emile Shebani Farik Marco Fiore J.E.F. Fitzgerald Samuel Ford Tatiana Garmanova Gaetano Gallo

The CovidSurg-Cancer Consortium aimed to explore the impact of COVID-19 in surgical patients and services for solid cancers at start pandemic. CovidSurg-Gynecologic Oncology Cancer subgroup was particularly concerned about magnitude adverse outcomes caused by disrupted gynecologic cancer care during pandemic, which are currently unclear.

10.1016/j.ajog.2022.06.052 article EN cc-by American Journal of Obstetrics and Gynecology 2022-06-30

Abstract Objective Patients with autoimmune diseases were advised to shield avoid coronavirus disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-day outcomes and mortality after hospitalization COVID-19 among patients prevalent diseases, compared hospital admissions similar seasonal influenza. Methods A multinational network cohort study was conducted using electronic health records data from Columbia University Irving Medical Center [USA, Optum...

10.1093/rheumatology/keab250 article EN cc-by Lara D. Veeken 2021-03-11

OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital treatments, and health outcomes among children adolescents diagnosed or hospitalized with coronavirus disease 2019 (COVID-19) to compare them in secondary analyses patients previous seasonal influenza 2017–2018. METHODS International network cohort using real-world data from European primary care records (France, Germany, Spain), South Korean claims US claims, hospital databases. We included and/or COVID-19 at...

10.1542/peds.2020-042929 article EN cc-by PEDIATRICS 2021-05-28

Abstract Background In this study we phenotyped individuals hospitalised with coronavirus disease 2019 (COVID-19) in depth, summarising entire medical histories, including medications, as captured routinely collected data drawn from databases across three continents. We then compared COVID-19 to those previously influenza. Methods report demographics, recorded conditions and medication use of patients the US (Columbia University Irving Medical Center [CUIMC], Premier Healthcare Database...

10.1101/2020.04.22.20074336 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2020-04-25

Abstract As the COVID-19 virus continues to infect people across globe, there is little understanding of long term implications for recovered patients. There have been reports persistent symptoms after confirmed infections on patients even three months initial recovery. While some these documented follow-ups clinical records, or participate in longitudinal surveys, datasets are usually not publicly available standardized perform analyses them. Therefore, a need use additional data sources...

10.1101/2020.07.29.20164418 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-08-01

Routinely collected real world data (RWD) have great utility in aiding the novel coronavirus disease (COVID-19) pandemic response. Here we present international Observational Health Data Sciences and Informatics (OHDSI) Characterizing Associated Risks Your Baseline Disease In SARS-COV-2 (CHARYBDIS) framework for standardisation analysis of COVID-19 RWD.

10.2147/clep.s323292 article EN cc-by-nc Clinical Epidemiology 2022-03-01

Abstract The ongoing Israeli military assault on Gaza has caused a devastating collapse of healthcare infrastructure, resulting in an unprecedented surge infectious diseases. destruction sanitation systems, restrictions medical supplies, and displacement civilians have created environment conducive to the rapid spread waterborne, vector‐borne, antibiotic‐resistant infections. This paper draws from insights local Palestinian workers recent missions conducted by FAJR Scientific, Palestine...

10.1002/wmh3.642 article EN cc-by World Medical & Health Policy 2024-11-06

Abstract Introduction Tranexamic acid (TXA) is an antifibrinolytic agent primarily used to prevent bleeding. In recent years, multiple studies have investigated its use in burn surgery. While some systematic reviews and meta-analyses been conducted, none comprehensively reviewed all available literature on this topic a way that effectively translates clinical application. A thorough well-organized review needed clarify current findings complex issue. Methods We conducted following PRISMA...

10.1093/jbcr/iraf019.166 article EN cc-by Journal of Burn Care & Research 2025-03-01
Coming Soon ...